{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T05:12:21Z","timestamp":1780636341209,"version":"3.54.1"},"reference-count":106,"publisher":"Bentham Science Publishers Ltd.","issue":"8","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:sec>\n<jats:title\/>\n<jats:p>The COVID-19 pandemic caused by the Severe Acute Respiratory Syndrome\nCoronavirus-2 (SARS-COV-2) is one of the biggest unsolved global problems of the 21&lt;sup&gt;st&lt;\/sup&gt;\ncentury for which there has been no definitive cure yet. Like other respiratory viruses,\nSARS-COV-2 triggers the host immunity dramatically, causing dysfunction in the\nimmune system, both innate and adaptive, which is a common feature of COVID-19\npatients. Evidence shows that in the early stages of COVID-19, the immune system is\nsuppressed while it is overactive in severe patients characterized by excessive and\nprolonged inflammatory responses called \"Cytokine Storm\". There are many elements in\nthe immune system that undergo alterations as the disease progresses. Some significant\nchanges in the innate immune system following infection with SARS-COV-2 include delayed\nor inhibited interferon type 1 production by the infected cells leading to elevated virus\nreplication, excessive recruitment of activated monocytes and macrophages, decrease\nin eosinophil population (eosinopenia), consequent decrease in CD&lt;sup&gt;8+&lt;\/sup&gt;T lymphocyte\nproliferation, natural killer (NK) cell dysfunction, and increase in neutrophil infiltration\n(neutrophilia) and neutrophil extracellular trap (NET) formation. Moreover, hallmark\nalterations in the adaptive immune system in this process cause an overall decrease in the\nT lymphocyte number (lymphopenia) and changes in the activity of some lymphocyte\nsubsets and a number of B cells. This review delves into the mentioned changes in the\nimmune system following SARS-COV-2 infection and the implications thereof to guide\nthe development of immunotherapies for patients with COVID-19.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0929867331666230918092749","type":"journal-article","created":{"date-parts":[[2023,9,19]],"date-time":"2023-09-19T04:05:42Z","timestamp":1695096342000},"page":"1575-1588","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["How does the Immunological System Change during the SARS-COV-2 Attack? A Clue for the New Immunotherapy Discovery"],"prefix":"10.2174","volume":"32","author":[{"given":"Mohammad Mahdi","family":"Hajihasani","sequence":"first","affiliation":[{"name":"Department of Pharmaceutical Control, School of Pharmacy, Mashhad University of Medical Sciences,\nMashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najmeh Kaffash","family":"Farkhad","sequence":"additional","affiliation":[{"name":"Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences,\nMashhad, Iran"},{"name":"Department of Immunology, Immunology Research Center, Faculty of Medicine, Mashhad\nUniversity of Medical Science, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Mahmoudi","sequence":"additional","affiliation":[{"name":"Department of Immunology, Immunology Research Center, Faculty of Medicine, Mashhad\nUniversity of Medical Science, Mashhad, Iran"},{"name":"Department of Medical Biotechnology and Nanotechnology,\nFaculty of Medicine, Mashhad University of Medical Science, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amirhossein","family":"Sahebkar","sequence":"additional","affiliation":[{"name":"Applied Biomedical\nResearch Center, Mashhad University of Medical Sciences, Mashhad, Iran"},{"name":"Biotechnology Research Center,\nPharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","DOI":"10.1101\/2020.01.24.919183","author":"Wu F.","year":"2020","unstructured":"Wu F.; Zhao S.; Yu B.; Chen Y-M.; Wang W.; Hu Y.; Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. BioRxiv  2020","journal-title":"BioRxiv"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.kisu.2021.12.001","volume":"12","author":"Hollenberg M.D.","year":"2022","unstructured":"Hollenberg M.D.; Epstein M.; The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: Pathophysiologic mechanisms and emerging therapeutic targets. Kidney Int Suppl  2022,12(1),48-62","journal-title":"Kidney Int Suppl"},{"key":"ref=3","first-page":"1","author":"Hu B.","year":"2020","unstructured":"Hu B.; Guo H.; Zhou P.; Shi Z-L.; Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol  2020,1-14","journal-title":"Nat Rev Microbiol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1172\/JCI137244","volume":"130","author":"Chen G.","year":"2020","unstructured":"Chen G.; Wu D.; Guo W.; Cao Y.; Huang D.; Wang H.; Wang T.; Zhang X.; Chen H.; Yu H.; Zhang X.; Zhang M.; Wu S.; Song J.; Chen T.; Han M.; Li S.; Luo X.; Zhao J.; Ning Q.; Clinical and immunological features of severe and moderate coronavirus disease 2019. J Clin Invest  2020,130(5),2620-2629","journal-title":"J Clin Invest"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/resp.13196","volume":"23","author":"Yin Y.","year":"2018","unstructured":"Yin Y.; Wunderink R.G.; MERS, SARS and other coronaviruses as causes of pneumonia. Respirology  2018,23(2),130-137","journal-title":"Respirology"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"364","DOI":"10.3389\/fcimb.2020.00364","volume":"10","author":"Jesenak M.","year":"2020","unstructured":"Jesenak M.; Brndiarova M.; Urbancikova I.; Rennerova Z.; Vojtkova J.; Bobcakova A.; Ostro R.; Banovcin P.; Immune parameters and COVID-19 infection-associations with clinical severity and diseases prognosis. Front Cell Infect Microbiol  2020,10,364","journal-title":"Front Cell Infect Microbiol"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1001\/jama.2020.1585","volume":"323","author":"Wang D.","year":"2020","unstructured":"Wang D.; Hu B.; Hu C.; Zhu F.; Liu X.; Zhang J.; Wang B.; Xiang H.; Cheng Z.; Xiong Y.; Zhao Y.; Li Y.; Wang X.; Peng Z.; Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus\u2013infected pneumonia in Wuhan, China. JAMA  2020,323(11),1061-1069","journal-title":"JAMA"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1007\/s00134-020-05985-9","volume":"46","author":"Zhang H.","year":"2020","unstructured":"Zhang H.; Penninger J.M.; Li Y.; Zhong N.; Slutsky A.S.; Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: Molecular mechanisms and potential therapeutic target. Intensive Care Med  2020,46(4),586-590","journal-title":"Intensive Care Med"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"659339","DOI":"10.3389\/fimmu.2021.659339","volume":"12","author":"Wehbe Z.","year":"2021","unstructured":"Wehbe Z.; Hammoud S.H.; Yassine H.M.; Fardoun M.; El-Yazbi A.F.; Eid A.H.; Molecular and biological mechanisms underlying gender differences in COVID-19 severity and mortality. Front Immunol  2021,12,659339","journal-title":"Front Immunol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.3389\/fphar.2020.00836","volume":"11","author":"Wehbe Z.","year":"2020","unstructured":"Wehbe Z.; Hammoud S.; Soudani N.; Zaraket H.; El-Yazbi A.; Eid A.H.; Molecular insights into SARS COV-2 interaction with cardiovascular disease: Role of RAAS and MAPK signaling. Front Pharmacol  2020,11,836","journal-title":"Front Pharmacol"},{"key":"ref=11","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.14.988345","author":"Wang K.","year":"2020","unstructured":"Wang K.; Chen W.; Zhou Y-S.; Lian J-Q.; Zhang Z.; Du P.; SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. BioRxiv  2020","journal-title":"BioRxiv"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"663586","DOI":"10.3389\/fimmu.2021.663586","volume":"12","author":"Wehbe Z.","year":"2021","unstructured":"Wehbe Z.; Wehbe M.; Iratni R.; Pintus G.; Zaraket H.; Yassine H.M.; Eid A.H.; Repurposing ivermectin for COVID-19: Molecular aspects and therapeutic possibilities. Front Immunol  2021,12,663586","journal-title":"Front Immunol"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1080\/14787210.2020.1822737","volume":"19","author":"Tajbakhsh A.","year":"2021","unstructured":"Tajbakhsh A.; Gheibi Hayat S.M.; Taghizadeh H.; Akbari A.; Inabadi M.; Savardashtaki A.; Johnston T.P.; Sahebkar A.; COVID-19 and cardiac injury: clinical manifestations, biomarkers, mechanisms, diagnosis, treatment, and follow up. Exp. Rev. Anti-infective Ther  2021,19(3),345-357","journal-title":"Anti-infective Ther"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.5114\/aoms\/152467","volume":"18","author":"Na-Bangchang K.","year":"2022","unstructured":"Na-Bangchang K.; Porasuphatana S.; Karbwang J.; Perspective: repurposed drugs for COVID-19. Arch Med Sci AMS  2022,18(5),1378-1391","journal-title":"Arch Med Sci AMS"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"1901772","DOI":"10.1155\/2021\/1901772","volume":"2021","author":"Vahedian-Azimi A.","year":"2021","unstructured":"Vahedian-Azimi A.; Mohammadi S.M.; Banach M.; Beni F.H.; Guest P.C.; Al-Rasadi K.; Jamialahmadi T.; Sahebkar A.; Improved COVID-19 outcomes following statin therapy: An updated systematic review and meta-analysis. BioMed Res Int  2021,2021,1901772","journal-title":"BioMed Res Int"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1056\/NEJM200007063430107","volume":"343","author":"Delves P.J.","year":"2000","unstructured":"Delves P.J.; Roitt I.M.; Delves P.J.; Roitt I.M.; The immune system. First of two parts. N Engl J Med  2000,343(1),37-49","journal-title":"N Engl J Med"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","volume":"7","author":"Zhou Y.","year":"2020","unstructured":"Zhou Y.; Fu B.; Zheng X.; Wang D.; Zhao C.; Qi Y.; Sun R.; Tian Z.; Xu X.; Wei H.; Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci Rev  2020,7(6),998-1002","journal-title":"Natl Sci Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1056\/NEJMoa2001017","volume":"382","author":"Zhu N.","year":"2020","unstructured":"Zhu N.; Zhang D.; Wang W.; Li X.; Yang B.; Song J.; Zhao X.; Huang B.; Shi W.; Lu R.; Niu P.; Zhan F.; Ma X.; Wang D.; Xu W.; Wu G.; Gao G.F.; Tan W.; A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med  2020,382(8),727-733","journal-title":"N Engl J Med"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"Zhou P.","year":"2020","unstructured":"Zhou P.; Yang X-L.; Wang X-G.; Hu B.; Zhang L.; Zhang W.; A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature  2020,579(7798),270-273","journal-title":"Nature"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1126\/science.abb2762","volume":"367","author":"Yan R.","year":"2020","unstructured":"Yan R.; Zhang Y.; Li Y.; Xia L.; Guo Y.; Zhou Q.; Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2. Science  2020,367(6485),1444-1448","journal-title":"Science"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1111\/tmi.13383","volume":"25","author":"Velavan T.P.","year":"2020","unstructured":"Velavan T.P.; Meyer C.G.; The COVID\u201019 epidemic. Trop Med Int Health  2020,25(3),278-280","journal-title":"Trop Med Int Health"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.jiph.2020.03.019","volume":"13","author":"Harapan H.","year":"2020","unstructured":"Harapan H.; Itoh N.; Yufika A.; Winardi W.; Keam S.; Te H.; Megawati D.; Hayati Z.; Wagner A.L.; Mudatsir M.; Coronavirus disease 2019 (COVID-19): A literature review. J Infect Public Health  2020,13(5),667-673","journal-title":"J Infect Public Health"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"e01925","DOI":"10.1128\/JVI.01925-19","volume":"94","author":"Cong Y.","year":"2020","unstructured":"Cong Y.; Ulasli M.; Schepers H.; Mauthe M.; V\u2019kovski P.; Kriegenburg F.; Thiel V.; de Haan C.A.M.; Reggiori F.; Nucleocapsid protein recruitment to replication-transcription complexes plays a crucial role in coronaviral life cycle. J Virol  2020,94(4),e01925-e19","journal-title":"J Virol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"360","DOI":"10.3390\/v12040360","volume":"12","author":"Srinivasan S.","year":"2020","unstructured":"Srinivasan S.; Cui H.; Gao Z.; Liu M.; Lu S.; Mkandawire W.; Narykov O.; Sun M.; Korkin D.; Structural genomics of SARS-CoV-2 indicates evolutionary conserved functional regions of viral proteins. Viruses  2020,12(4),360","journal-title":"Viruses"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.vacun.2020.09.005","volume":"22","author":"Dawood A.A.","year":"2021","unstructured":"Dawood A.A.; Glycosylation, ligand binding sites and antigenic variations between membrane glycoprotein of COVID-19 and related coronaviruses. Vacunas  2021,22(1),1-9","journal-title":"Vacunas"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"e1004077","DOI":"10.1371\/journal.ppat.1004077","volume":"10","author":"Nieto-Torres J.L.","year":"2014","unstructured":"Nieto-Torres J.L.; DeDiego M.L.; Verdi&#xE1;-B&#xE1;guena C.; Jimenez-Guarde&#xF1;o J.M.; Regla-Nava J.A.; Fernandez-Delgado R.; Casta&#xF1;o-Rodriguez C.; Alcaraz A.; Torres J.; Aguilella V.M.; Enjuanes L.; Severe acute respiratory syndrome coronavirus envelope protein ion channel activity promotes virus fitness and pathogenesis. PLoS Pathog  2014,10(5),e1004077","journal-title":"PLoS Pathog"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1038\/nsmb1123","volume":"13","author":"Beniac D.R.","year":"2006","unstructured":"Beniac D.R.; Andonov A.; Grudeski E.; Booth T.F.; Architecture of the SARS coronavirus prefusion spike. Nat Struct Mol Biol  2006,13(8),751-752","journal-title":"Nat Struct Mol Biol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1080\/22221751.2020.1746199","volume":"9","author":"Lin L.","year":"2020","unstructured":"Lin L.; Lu L.; Cao W.; Li T.; Hypothesis for potential pathogenesis of SARS-CoV-2 infection\u2013a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect  2020,9(1),727-732","journal-title":"Emerg Microbes Infect"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","volume":"426","author":"Li W.","year":"2003","unstructured":"Li W.; Moore M.J.; Vasilieva N.; Sui J.; Wong S.K.; Berne M.A.; Somasundaran M.; Sullivan J.L.; Luzuriaga K.; Greenough T.C.; Choe H.; Farzan M.; Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature  2003,426(6965),450-454","journal-title":"Nature"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/s41586-020-2179-y","volume":"581","author":"Shang J.","year":"2020","unstructured":"Shang J.; Ye G.; Shi K.; Wan Y.; Luo C.; Aihara H.; Geng Q.; Auerbach A.; Li F.; Structural basis of receptor recognition by SARS-CoV-2. Nature  2020,581(7807),221-224","journal-title":"Nature"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1146\/annurev-virology-110615-042301","volume":"3","author":"Li F.","year":"2016","unstructured":"Li F.; Structure, function, and evolution of coronavirus spike proteins. Annu Rev Virol  2016,3(1),237-261","journal-title":"Annu Rev Virol"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","volume":"181","author":"Walls A.C.","year":"2020","unstructured":"Walls A.C.; Park Y-J.; Tortorici M.A.; Wall A.; McGuire A.T.; Veesler D.; Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell  2020,181(2),281-92.e6","journal-title":"Cell"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"104543","DOI":"10.1016\/j.jcv.2020.104543","volume":"129","author":"Hirotsu Y.","year":"2020","unstructured":"Hirotsu Y.; Maejima M.; Shibusawa M.; Amemiya K.; Nagakubo Y.; Hosaka K.; Sueki H.; Mochizuki H.; Tsutsui T.; Kakizaki Y.; Miyashita Y.; Omata M.; Analysis of COVID-19 and non-COVID-19 viruses, including influenza viruses, to determine the influence of intensive preventive measures in Japan. J Clin Virol  2020,129,104543","journal-title":"J Clin Virol"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.anorl.2020.05.015","volume":"137","author":"de Gabory L.","year":"2020","unstructured":"de Gabory L.; Alharbi A.; K&#xE9;rimian M.; Lafon M.E.; The influenza virus, SARS-CoV-2, and the airways: Clarification for the otorhinolaryngologist. Eur Ann Otorhinolaryngol Head Neck Dis  2020,137(4),291-296","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1016\/S0140-6736(00)04904-7","volume":"357","author":"Parkin J.","year":"2001","unstructured":"Parkin J.; Cohen B.; An overview of the immune system. Lancet  2001,357(9270),1777-1789","journal-title":"Lancet"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1093\/ajcn.83.3.567","volume":"83","author":"Wannamethee S.G.","year":"2006","unstructured":"Wannamethee S.G.; Lowe G.D.O.; Rumley A.; Bruckdorfer K.R.; Whincup P.H.; Associations of vitamin C status, fruit and vegetable intakes, and markers of inflammation and hemostasis. Am J Clin Nutr  2006,83(3),567-574","journal-title":"Am J Clin Nutr"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3389\/fimmu.2019.01745","volume":"10","author":"Schnappauf O.","year":"2019","unstructured":"Schnappauf O.; Chae J.J.; Kastner D.L.; Aksentijevich I.; The pyrin inflammasome in health and disease. Front Immunol  2019,10,1745","journal-title":"Front Immunol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1146\/annurev-pathol-020117-043625","volume":"13","author":"Al-Samkari H.","year":"2018","unstructured":"Al-Samkari H.; Berliner N.; Hemophagocytic lymphohistiocytosis. Annu Rev Pathol  2018,13,27-49","journal-title":"Annu Rev Pathol"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","volume":"395","author":"Mehta P.","year":"2020","unstructured":"Mehta P.; McAuley D.F.; Brown M.; Sanchez E.; Tattersall R.S.; Manson J.J.; COVID-19: Consider cytokine storm syndromes and immunosuppression. Lancet  2020,395(10229),1033-1034","journal-title":"Lancet"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"476","DOI":"10.3390\/pathogens10040476","volume":"10","author":"Lauro R.","year":"2021","unstructured":"Lauro R.; Irrera N.; Eid A.H.; Bitto A.; Could antigen presenting cells represent a protective element during SARS-CoV-2 infection in children? Pathogens  2021,10(4),476","journal-title":"Pathogens"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"5859","DOI":"10.1038\/s41467-020-19706-9","volume":"11","author":"Tian W.","year":"2020","unstructured":"Tian W.; Zhang N.; Jin R.; Feng Y.; Wang S.; Gao S.; Gao R.; Wu G.; Tian D.; Tan W.; Chen Y.; Gao G.F.; Wong C.C.L.; Immune suppression in the early stage of COVID-19 disease. Nat Commun  2020,11(1),5859","journal-title":"Nat Commun"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1126\/science.abc6261","volume":"369","author":"Arunachalam P.S.","year":"2020","unstructured":"Arunachalam P.S.; Wimmers F.; Mok C.K.P.; Perera R.A.P.M.; Scott M.; Hagan T.; Sigal N.; Feng Y.; Bristow L.; Tak-Yin Tsang O.; Wagh D.; Coller J.; Pellegrini K.L.; Kazmin D.; Alaaeddine G.; Leung W.S.; Chan J.M.C.; Chik T.S.H.; Choi C.Y.C.; Huerta C.; Paine McCullough M.; Lv H.; Anderson E.; Edupuganti S.; Upadhyay A.A.; Bosinger S.E.; Maecker H.T.; Khatri P.; Rouphael N.; Peiris M.; Pulendran B.; Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science  2020,369(6508),1210-1220","journal-title":"Science"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41577-020-0311-8","volume":"20","author":"Tay M.Z.","year":"2020","unstructured":"Tay M.Z.; Poh C.M.; R&#xE9;nia L.; MacAry P.A.; Ng L.F.P.; The trinity of COVID-19: Immunity, inflammation and intervention. Nat Rev Immunol  2020,20(6),363-374","journal-title":"Nat Rev Immunol"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/rth2.12462","volume":"5","author":"von Meijenfeldt F.A.","year":"2021","unstructured":"von Meijenfeldt F.A.; Havervall S.; Adelmeijer J.; Lundstr&#xF6;m A.; Rudberg A.S.; Magnusson M.; Mackman N.; Thalin C.; Lisman T.; Prothrombotic changes in patients with COVID\u201019 are associated with disease severity and mortality. Res Pract Thromb Haemost  2021,5(1),132-141","journal-title":"Res Pract Thromb Haemost"},{"key":"ref=45","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3551623","author":"Zhou Z.","year":"2020","unstructured":"Zhou Z.; Ren L.; Zhang L.; Zhong J.; Xiao Y.; Jia Z.; Overly exuberant innate immune response to SARS-CoV-2 infection. Cell Host Microbe  2020","journal-title":"Cell Host Microbe"},{"key":"ref=46","first-page":"1","volume":"6","author":"Wen W.","year":"2020","unstructured":"Wen W.; Su W.; Tang H.; Le W.; Zhang X.; Zheng Y.; Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov  2020,6(1),1-18","journal-title":"Cell Discov"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/JLB.4HI0720-470R","volume":"109","author":"Zhang D.","year":"2020","unstructured":"Zhang D.; Guo R.; Lei L.; Liu H.; Wang Y.; Wang Y.; COVID\u201019 infection induces readily detectable morphologic and inflammation\u2010related phenotypic changes in peripheral blood monocytes. J Leukoc Biol  2020,109(1),13-22","journal-title":"J Leukoc Biol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1111\/all.14353","volume":"75","author":"Jesenak M.","year":"2020","unstructured":"Jesenak M.; Banovcin P.; Diamant Z.; COVID\u201019, chronic inflammatory respiratory diseases and eosinophils\u2014Observations from reported clinical case series. Allergy  2020,75(7),1819-1822","journal-title":"Allergy"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1089\/vim.2018.0150","volume":"32","author":"Flores-Torres A.S.","year":"2019","unstructured":"Flores-Torres A.S.; Salinas-Carmona M.C.; Salinas E.; Rosas-Taraco A.G.; Eosinophils and respiratory viruses. Viral Immunol  2019,32(5),198-207","journal-title":"Viral Immunol"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","volume":"63","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Yang Y.; Zhang C.; Huang F.; Wang F.; Yuan J.; Wang Z.; Li J.; Li J.; Feng C.; Zhang Z.; Wang L.; Peng L.; Chen L.; Qin Y.; Zhao D.; Tan S.; Yin L.; Xu J.; Zhou C.; Jiang C.; Liu L.; Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury. Sci China Life Sci  2020,63(3),364-374","journal-title":"Sci China Life Sci"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.cca.2020.05.027","volume":"508","author":"Sun D.","year":"2020","unstructured":"Sun D.; Zhang D.; Tian R.; Li Y.; Wang Y.; Cao J.; Tang Y.; Zhang N.; Zan T.; Gao L.; Huang Y.; Cui C.; Wang D.; Zheng Y.; Lv G.; The underlying changes and predicting role of peripheral blood inflammatory cells in severe COVID-19 patients: A sentinel? Clin Chim Acta  2020,508,122-129","journal-title":"Clin Chim Acta"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/all.14465","volume":"76","author":"Xie G.","year":"2021","unstructured":"Xie G.; Ding F.; Han L.; Yin D.; Lu H.; Zhang M.; The role of peripheral blood eosinophil counts in COVID\u201019 patients. Allergy  2021,76(2),471-482","journal-title":"Allergy"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"100521","DOI":"10.1016\/j.waojou.2021.100521","volume":"14","author":"Yan B.","year":"2021","unstructured":"Yan B.; Yang J.; Xie Y.; Tang X.; Relationship between blood eosinophil levels and COVID-19 mortality. World Allergy Organ J  2021,14(3),100521","journal-title":"World Allergy Organ J"},{"key":"ref=54","author":"Tan B.H.J.","year":"2004","unstructured":"Tan B.H.J.;  Host defense against intracellular pathogens  2004","journal-title":"Host defense against intracellular pathogens"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"e01753","DOI":"10.1128\/mBio.01753-18","volume":"9","author":"Gralinski L.E.","year":"2018","unstructured":"Gralinski L.E.; Sheahan T.P.; Morrison T.E.; Menachery V.D.; Jensen K.; Leist S.R.; Whitmore A.; Heise M.T.; Baric R.S.; Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis. MBio  2018,9(5),e01753-e18","journal-title":"MBio"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"e20200652","DOI":"10.1084\/jem.20200652","volume":"217","author":"Barnes B.J.","year":"2020","unstructured":"Barnes B.J.; Adrover J.M.; Baxter-Stoltzfus A.; Borczuk A.; Cools-Lartigue J.; Crawford J.M.; Da&#xDF;ler-Plenker J.; Guerci P.; Huynh C.; Knight J.S.; Loda M.; Looney M.R.; McAllister F.; Rayes R.; Renaud S.; Rousseau S.; Salvatore S.; Schwartz R.E.; Spicer J.D.; Yost C.C.; Weber A.; Zuo Y.; Egeblad M.; Targeting potential drivers of COVID-19: Neutrophil extracellular traps. J Exp Med  2020,217(6),e20200652","journal-title":"J Exp Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"e6","DOI":"10.1016\/j.jinf.2020.04.002","volume":"81","author":"Liu Y.","year":"2020","unstructured":"Liu Y.; Du X.; Chen J.; Jin Y.; Peng L.; Wang H.H.X.; Luo M.; Chen L.; Zhao Y.; Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19. J Infect  2020,81(1),e6-e12","journal-title":"J Infect"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.thromres.2020.05.006","volume":"192","author":"Fu J.","year":"2020","unstructured":"Fu J.; Kong J.; Wang W.; Wu M.; Yao L.; Wang Z.; Jin J.; Wu D.; Yu X.; The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thromb Res  2020,192,3-8","journal-title":"Thromb Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/j.0105-2896.2010.00906.x","volume":"235","author":"Paust S.","year":"2010","unstructured":"Paust S.; Senman B.; Von Andrian U.H.; Adaptive immune responses mediated by natural killer cells. Immunol Rev  2010,235(1),286-296","journal-title":"Immunol Rev"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/nature07665","volume":"457","author":"Sun J.C.","year":"2009","unstructured":"Sun J.C.; Beilke J.N.; Lanier L.L.; Adaptive immune features of natural killer cells. Nature  2009,457(7229),557-561","journal-title":"Nature"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/35095564","volume":"1","author":"Cerwenka A.","year":"2001","unstructured":"Cerwenka A.; Lanier L.L.; Natural killer cells, viruses and cancer. Nat Rev Immunol  2001,1(1),41-49","journal-title":"Nat Rev Immunol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1084\/jem.20181454","volume":"216","author":"Prager I.","year":"2019","unstructured":"Prager I.; Liesche C.; van Ooijen H.; Urlaub D.; Verron Q.; Sandstr&#xF6;m N.; Fasbender F.; Claus M.; Eils R.; Beaudouin J.; &#xD6;nfelt B.; Watzl C.; NK cells switch from granzyme B to death receptor\u2013mediated cytotoxicity during serial killing. J Exp Med  2019,216(9),2113-2127","journal-title":"J Exp Med"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1309\/WPK7Y2XKNF4CBF3R","volume":"121","year":"2004","unstructured":"National Research Project for SARS Beijing Group. The involvement of natural killer cells in the pathogenesis of severe acute respiratory syndrome. Am J Clin Pathol  2004,121(4),507-511","journal-title":"Am J Clin Pathol"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","volume":"20","author":"Acharya D.","year":"2020","unstructured":"Acharya D.; Liu G.; Gack M.U.; Dysregulation of type I interferon responses in COVID-19. Nat Rev Immunol  2020,20(7),397-398","journal-title":"Nat Rev Immunol"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.3389\/fimmu.2019.02247","volume":"10","author":"Aiello A.","year":"2019","unstructured":"Aiello A.; Farzaneh F.; Candore G.; Caruso C.; Davinelli S.; Gambino C.M.; Ligotti M.E.; Zareian N.; Accardi G.; Immunosenescence and its hallmarks: How to oppose aging strategically? A review of potential options for therapeutic intervention. Front Immunol  2019,10,2247","journal-title":"Front Immunol"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1097\/CM9.0000000000000824","volume":"133","author":"Deng Y.","year":"2020","unstructured":"Deng Y.; Liu W.; Liu K.; Fang Y.Y.; Shang J.; Zhou L.; Wang K.; Leng F.; Wei S.; Chen L.; Liu H.G.; Clinical characteristics of fatal and recovered cases of coronavirus disease 2019 in Wuhan, China: A retrospective study. Chin Med J  2020,133(11),1261-1267","journal-title":"Chin Med J"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/j.jinf.2020.02.016","volume":"80","author":"Yang W.","year":"2020","unstructured":"Yang W.; Cao Q.; Qin L.; Wang X.; Cheng Z.; Pan A.; Dai J.; Sun Q.; Zhao F.; Qu J.; Yan F.; Clinical characteristics and imaging manifestations of the 2019 novel coronavirus disease (COVID-19):A multi-center study in Wenzhou city, Zhejiang, China. J Infect  2020,80(4),388-393","journal-title":"J Infect"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-019-0089-y","volume":"5","author":"Li D.","year":"2020","unstructured":"Li D.; Chen Y.; Liu H.; Jia Y.; Li F.; Wang W.; Immune dysfunction leads to mortality and organ injury in patients with COVID-19 in China: insights from ERS-COVID-19 study. Signal Transduct Target Ther  2020,5(1),1-3","journal-title":"Signal Transduct Target Ther"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.1128\/JVI.01281-09","volume":"84","author":"Chen J.","year":"2010","unstructured":"Chen J.; Lau Y.F.; Lamirande E.W.; Paddock C.D.; Bartlett J.H.; Zaki S.R.; Subbarao K.; Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB\/c mice: CD4+ T cells are important in control of SARS-CoV infection. J Virol  2010,84(3),1289-1301","journal-title":"J Virol"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"9318","DOI":"10.1128\/JVI.01049-10","volume":"84","author":"Zhao J.","year":"2010","unstructured":"Zhao J.; Zhao J.; Perlman S.; T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. J Virol  2010,84(18),9318-9325","journal-title":"J Virol"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"360","DOI":"10.4049\/jimmunol.1800986","volume":"202","author":"Koutsakos M.","year":"2019","unstructured":"Koutsakos M.; Nguyen T.H.O.; Kedzierska K.; With a little help from T follicular helper friends: Humoral immunity to influenza vaccination. J Immunol  2019,202(2),360-367","journal-title":"J Immunol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/j.cell.2020.05.015","volume":"181","author":"Grifoni A.","year":"2020","unstructured":"Grifoni A.; Weiskopf D.; Ramirez S.I.; Mateus J.; Dan J.M.; Moderbacher C.R.; Targets of T cell responses to SARS-CoV-2 coronavirus in humans with COVID-19 disease and unexposed individuals. Cell  2020,181(7),1489-501.e15","journal-title":"Cell"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"120392","DOI":"10.1016\/j.lfs.2022.120392","volume":"294","author":"Saghafi N.","year":"2022","unstructured":"Saghafi N.; Rezaee S.A.; Momtazi-Borojeni A.A.; Tavasolian F.; Sathyapalan T.; Abdollahi E.; Sahebkar A.; The therapeutic potential of regulatory T cells in reducing cardiovascular complications in patients with severe COVID-19. Life Sci  2022,294,120392","journal-title":"Life Sci"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1038\/s41467-020-17292-4","volume":"11","author":"De Biasi S.","year":"2020","unstructured":"De Biasi S.; Meschiari M.; Gibellini L.; Bellinazzi C.; Borella R.; Fidanza L.; Gozzi L.; Iannone A.; Lo Tartaro D.; Mattioli M.; Paolini A.; Menozzi M.; Mili\u0107 J.; Franceschi G.; Fantini R.; Tonelli R.; Sita M.; Sarti M.; Trenti T.; Brugioni L.; Cicchetti L.; Facchinetti F.; Pietrangelo A.; Clini E.; Girardis M.; Guaraldi G.; Mussini C.; Cossarizza A.; Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia. Nat Commun  2020,11(1),3434","journal-title":"Nat Commun"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","volume":"80","author":"Ye Q.","year":"2020","unstructured":"Ye Q.; Wang B.; Mao J.; The pathogenesis and treatment of the \u2018Cytokine Storm\u2019 in COVID-19. J Infect  2020,80(6),607-613","journal-title":"J Infect"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/j.exger.2013.09.003","volume":"48","author":"Schmitt V.","year":"2013","unstructured":"Schmitt V.; Rink L.; Uciechowski P.; The Th17\/Treg balance is disturbed during aging. Exp Gerontol  2013,48(12),1379-1386","journal-title":"Exp Gerontol"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1007\/s11357-020-00186-0","volume":"42","author":"Nikolich-Zugich J.","year":"2020","unstructured":"Nikolich-Zugich J.; Knox K.S.; Rios C.T.; Natt B.; Bhattacharya D.; Fain M.J.; SARS-CoV-2 and COVID-19 in older adults: what we may expect regarding pathogenesis, immune responses, and outcomes. Geroscience  2020,42(2),505-514","journal-title":"Geroscience"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.reth.2021.05.007","volume":"18","author":"Kaffash Farkhad N.","year":"2021","unstructured":"Kaffash Farkhad N.; Reihani H.; sedaghat, A.; Moghadam, A.A.; Moghadam, A.B.; Tavakol-Afshari, J. Are mesenchymal stem cells able to manage cytokine storm in COVID-19 patients? A review of recent studies. Regen Ther  2021,18,152-160","journal-title":"Regen Ther"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1093\/cid\/ciaa248","volume":"71","author":"Qin C.","year":"2020","unstructured":"Qin C.; Zhou L.; Hu Z.; Zhang S.; Yang S.; Tao Y.; Xie C.; Ma K.; Shang K.; Wang W.; Tian D.S.; Dysregulation of immune response in patients with coronavirus 2019 (COVID-19) in Wuhan, China. Clin Infect Dis  2020,71(15),762-768","journal-title":"Clin Infect Dis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1136\/gutjnl-2020-321269","volume":"69","author":"Neurath M.F.","year":"2020","unstructured":"Neurath M.F.; COVID-19 and immunomodulation in IBD. Gut  2020,69(7),1335-1342","journal-title":"Gut"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","volume":"104","author":"Mahallawi W.H.","year":"2018","unstructured":"Mahallawi W.H.; Khabour O.F.; Zhang Q.; Makhdoum H.M.; Suliman B.A.; MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile. Cytokine  2018,104,8-13","journal-title":"Cytokine"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"e00165","DOI":"10.1128\/mBio.00165-13","volume":"4","author":"Josset L.","year":"2013","unstructured":"Josset L.; Menachery V.D.; Gralinski L.E.; Agnihothram S.; Sova P.; Carter V.S.; Yount B.L.; Graham R.L.; Baric R.S.; Katze M.G.; Cell host response to infection with novel human coronavirus EMC predicts potential antivirals and important differences with SARS coronavirus. MBio  2013,4(3),e00165-e13","journal-title":"MBio"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"e88716","DOI":"10.1371\/journal.pone.0088716","volume":"9","author":"Faure E.","year":"2014","unstructured":"Faure E.; Poissy J.; Goffard A.; Fournier C.; Kipnis E.; Titecat M.; Bortolotti P.; Martinez L.; Dubucquoi S.; Dessein R.; Gosset P.; Mathieu D.; Guery B.; Distinct immune response in two MERS-CoV-infected patients: Can we go from bench to bedside? PLoS One  2014,9(2),e88716","journal-title":"PLoS One"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"e2111315118","DOI":"10.1073\/pnas.2111315118","volume":"118","author":"Galv&#xE1;n-Pe&#xF1;a S.","year":"2021","unstructured":"Galv&#xE1;n-Pe&#xF1;a S.; Leon J.; Chowdhary K.; Michelson D.A.; Vijaykumar B.; Yang L.; Magnuson A.M.; Chen F.; Manickas-Hill Z.; Piechocka-Trocha A.; Worrall D.P.; Hall K.E.; Ghebremichael M.; Walker B.D.; Li J.Z.; Yu X.G.; Mathis D.; Benoist C.; Lavin-Parsons K.; Parry B.; Lilley B.; Lodenstein C.; McKaig B.; Charland N.; Khanna H.; Margolin J.; Gonye A.; Gushterova I.; Lasalle T.; Sharma N.; Russo B.C.; Rojas-Lopez M.; Sade-Feldman M.; Manakongtreecheep K.; Tantivit J.; Thomas M.F.; Profound Treg perturbations correlate with COVID-19 severity. Proc Natl Acad Sci  2021,118(37),e2111315118","journal-title":"Proc Natl Acad Sci"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"155439","DOI":"10.1016\/j.cyto.2021.155439","volume":"140","author":"Sami R.","year":"2021","unstructured":"Sami R.; Fathi F.; Eskandari N.; Ahmadi M.; ArefNezhad, R.; Motedayyen, H. Characterizing the immune responses of those who survived or succumbed to COVID-19: Can immunological signatures predict outcome? Cytokine  2021,140,155439","journal-title":"Cytokine"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/j.virol.2008.12.014","volume":"385","author":"Anghelina D.","year":"2009","unstructured":"Anghelina D.; Zhao J.; Trandem K.; Perlman S.; Role of regulatory T cells in coronavirus-induced acute encephalitis. Virology  2009,385(2),358-367","journal-title":"Virology"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"852","DOI":"10.7326\/L20-0681","volume":"173","author":"Gladstone D.E.","year":"2020","unstructured":"Gladstone D.E.; Kim B.S.; Mooney K.; Karaba A.H.; D\u2019Alessio F.R.; Regulatory T cells for treating patients with COVID-19 and acute respiratory distress syndrome: two case reports. Ann Intern Med  2020,173(10),852-853","journal-title":"Ann Intern Med"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"2829","DOI":"10.1002\/jcp.30047","volume":"236","author":"Sadeghi A.","year":"2021","unstructured":"Sadeghi A.; Tahmasebi S.; Mahmood A.; Kuznetsova M.; Valizadeh H.; Taghizadieh A.; Nazemiyeh M.; Aghebati-Maleki L.; Jadidi-Niaragh F.; Abbaspour-Aghdam S.; Roshangar L.; Mikaeili H.; Ahmadi M.; Th17 and Treg cells function in SARS\u2010CoV2 patients compared with healthy controls. J Cell Physiol  2021,236(4),2829-2839","journal-title":"J Cell Physiol"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"Diao B.","year":"2020","unstructured":"Diao B.; Wang C.; Tan Y.; Chen X.; Liu Y.; Ning L.; Chen L.; Li M.; Liu Y.; Wang G.; Yuan Z.; Feng Z.; Zhang Y.; Wu Y.; Chen Y.; Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol  2020,11,827","journal-title":"Front Immunol"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/S2213-2600(20)30076-X","volume":"8","author":"Xu Z.","year":"2020","unstructured":"Xu Z.; Shi L.; Wang Y.; Zhang J.; Huang L.; Zhang C.; Liu S.; Zhao P.; Liu H.; Zhu L.; Tai Y.; Bai C.; Gao T.; Song J.; Xia P.; Dong J.; Zhao J.; Wang F.S.; Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med  2020,8(4),420-422","journal-title":"Lancet Respir Med"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41586-019-1593-5","volume":"574","author":"Demaria O.","year":"2019","unstructured":"Demaria O.; Cornen S.; Da&#xEB;ron M.; Morel Y.; Medzhitov R.; Vivier E.; Harnessing innate immunity in cancer therapy. Nature  2019,574(7776),45-56","journal-title":"Nature"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/1742-4933-11-4","volume":"11","author":"Clay C.C.","year":"2014","unstructured":"Clay C.C.; Donart N.; Fomukong N.; Knight J.B.; Overheim K.; Tipper J.; Van Westrienen J.; Hahn F.; Harrod K.S.; Severe acute respiratory syndrome-coronavirus infection in aged nonhuman primates is associated with modulated pulmonary and systemic immune responses. Immun Ageing  2014,11(1),4","journal-title":"Immun Ageing"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1093\/infdis\/jiaa150","volume":"221","author":"Wang F.","year":"2020","unstructured":"Wang F.; Nie J.; Wang H.; Zhao Q.; Xiong Y.; Deng L.; Song S.; Ma Z.; Mo P.; Zhang Y.; Characteristics of peripheral lymphocyte subset alteration in COVID-19 pneumonia. J Infect Dis  2020,221(11),1762-1769","journal-title":"J Infect Dis"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41423-020-0401-3","volume":"17","author":"Zheng H.Y.","year":"2020","unstructured":"Zheng H.Y.; Zhang M.; Yang C.X.; Zhang N.; Wang X.C.; Yang X.P.; Dong X.Q.; Zheng Y.T.; Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol  2020,17(5),541-543","journal-title":"Cell Mol Immunol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1016\/j.jinf.2020.04.012","volume":"81","author":"Xu B.","year":"2020","unstructured":"Xu B.; Fan C.; Wang A.; Zou Y.; Yu Y.; He C.; Xia W.; Zhang J.; Miao Q.; Suppressed T cell-mediated immunity in patients with COVID-19: A clinical retrospective study in Wuhan, China. J Infect  2020,81(1),e51-e60","journal-title":"J Infect"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.4049\/jimmunol.2000717","volume":"205","author":"Varnait\u0117 R.","year":"2020","unstructured":"Varnait\u0117 R.; Garc&#xED;a M.; Glans H.; Maleki K.T.; Sandberg J.T.; Tynell J.; Christ W.; Lagerqvist N.; Asgeirsson H.; Ljunggren H.G.; Ahl&#xE9;n G.; Frelin L.; S&#xE4;llberg M.; Blom K.; Klingstr&#xF6;m J.; Gredmark-Russ S.; Expansion of SARS-CoV-2\u2013specific antibody-secreting cells and generation of neutralizing antibodies in hospitalized COVID-19 patients. J Immunol  2020,205(9),2437-2446","journal-title":"J Immunol"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.3389\/fimmu.2020.02075","volume":"11","author":"He B.","year":"2020","unstructured":"He B.; Wang J.; Wang Y.; Zhao J.; Huang J.; Tian Y.; Yang C.; Zhang H.; Zhang M.; Gu L.; Zhou X.; Zhou J.; The metabolic changes and immune profiles in patients with COVID-19. Front Immunol  2020,11,2075","journal-title":"Front Immunol"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"102763","DOI":"10.1016\/j.ebiom.2020.102763","volume":"55","author":"Liu J.","year":"2020","unstructured":"Liu J.; Li S.; Liu J.; Liang B.; Wang X.; Wang H.; Li W.; Tong Q.; Yi J.; Zhao L.; Xiong L.; Guo C.; Tian J.; Luo J.; Yao J.; Pang R.; Shen H.; Peng C.; Liu T.; Zhang Q.; Wu J.; Xu L.; Lu S.; Wang B.; Weng Z.; Han C.; Zhu H.; Zhou R.; Zhou H.; Chen X.; Ye P.; Zhu B.; Wang L.; Zhou W.; He S.; He Y.; Jie S.; Wei P.; Zhang J.; Lu Y.; Wang W.; Zhang L.; Li L.; Zhou F.; Wang J.; Dittmer U.; Lu M.; Hu Y.; Yang D.; Zheng X.; Longitudinal characteristics of lymphocyte responses and cytokine profiles in the peripheral blood of SARS-CoV-2 infected patients. EBioMedicine  2020,55,102763","journal-title":"EBioMedicine"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"108590","DOI":"10.1016\/j.celrep.2020.108590","volume":"34","author":"Yao C.","year":"2021","unstructured":"Yao C.; Bora S.A.; Parimon T.; Zaman T.; Friedman O.A.; Palatinus J.A.; Surapaneni N.S.; Matusov Y.P.; Cerro Chiang G.; Kassar A.G.; Patel N.; Green C.E.R.; Aziz A.W.; Suri H.; Suda J.; Lopez A.A.; Martins G.A.; Stripp B.R.; Gharib S.A.; Goodridge H.S.; Chen P.; Cell-type-specific immune dysregulation in severely Ill COVID-19 Patients. Cell Rep  2021,34(1),108590","journal-title":"Cell Rep"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1002\/art.41380","volume":"72","author":"Fallet B.","year":"2020","unstructured":"Fallet B.; Kyburz D.; Walker U.A.; Mild course of Coronavirus disease 2019 and spontaneous severe acute respiratory syndrome coronavirus 2 clearance in a patient with depleted peripheral blood B\u2010cells due to treatment with rituximab. Arthritis Rheumatol  2020,72(9),1581-1582","journal-title":"Arthritis Rheumatol"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"103492","DOI":"10.1016\/j.resp.2020.103492","volume":"280","author":"Mattos-Silva P.","year":"2020","unstructured":"Mattos-Silva P.; Felix N.S.; Silva P.L.; Robba C.; Battaglini D.; Pelosi P.; Rocco P.R.M.; Cruz F.F.; Pros and cons of corticosteroid therapy for COVID-19 patients. Respir Physiol Neurobiol  2020,280,103492","journal-title":"Respir Physiol Neurobiol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"e0237693","DOI":"10.1371\/journal.pone.0237693","volume":"15","author":"Ip A.","year":"2020","unstructured":"Ip A.; Berry D.A.; Hansen E.; Goy A.H.; Pecora A.L.; Sinclaire B.A.; Bednarz U.; Marafelias M.; Berry S.M.; Berry N.S.; Mathura S.; Sawczuk I.S.; Biran N.; Go R.C.; Sperber S.; Piwoz J.A.; Balani B.; Cicogna C.; Sebti R.; Zuckerman J.; Rose K.M.; Tank L.; Jacobs L.G.; Korcak J.; Timmapuri S.L.; Underwood J.P.; Sugalski G.; Barsky C.; Varga D.W.; Asif A.; Landolfi J.C.; Goldberg S.L.; Hydroxychloroquine and tocilizumab therapy in COVID-19 patients\u2014An observational study. PLoS One  2020,15(8),e0237693","journal-title":"PLoS One"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/j.jinf.2020.04.017","volume":"81","author":"Cantini F.","year":"2020","unstructured":"Cantini F.; Niccoli L.; Matarrese D.; Nicastri E.; Stobbione P.; Goletti D.; Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact. J Infect  2020,81(2),318-356","journal-title":"J Infect"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s13287-022-02920-1","volume":"13","author":"Kaffash Farkhad N.","year":"2022","unstructured":"Kaffash Farkhad N.; Sedaghat A.; Reihani H.; Adhami Moghadam A.; Bagheri Moghadam A.; Khadem Ghaebi N.; Khodadoust M.A.; Ganjali R.; Tafreshian A.R.; Tavakol-Afshari J.; Mesenchymal stromal cell therapy for COVID-19-induced ARDS patients: A successful phase 1, control-placebo group, clinical trial. Stem Cell Res Ther  2022,13(1),283","journal-title":"Stem Cell Res Ther"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.reth.2022.03.006","volume":"20","author":"Kaffash Farkhad N.","year":"2022","unstructured":"Kaffash Farkhad N.; Mahmoudi A.; Mahdipour E.; Regenerative therapy by using mesenchymal stem cells-derived exosomes in COVID-19 treatment. The potential role and underlying mechanisms. Regen Ther  2022,20,61-71","journal-title":"Regen Ther"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"e00072","DOI":"10.1128\/CMR.00072-20","volume":"33","author":"Focosi D.","year":"2020","unstructured":"Focosi D.; Anderson A.O.; Tang J.W.; Tuccori M.; Convalescent plasma therapy for COVID-19: State of the art. Clin Microbiol Rev  2020,33(4),e00072-e20","journal-title":"Clin Microbiol Rev"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230918092749","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/221193\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0929867331666230918092749","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,25]],"date-time":"2025-03-25T11:38:00Z","timestamp":1742902680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/221193\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":106,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0929867331666230918092749","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2023-02-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-06-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-02-27","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}